AZTherapies
Latest round
- Series C
Last raised
- Sep 2020
Total raised
- $45M
Investors
- 10
About AZTherapies
Founded in 2011 and based in Massachusetts, US, AZTherapies Inc. operates as a biotechnology company that develops pharmaceutical drugs used for multiple neurodegenerations and neuroinflammation-related CNS diseases. The company's platform also develops ALZT-OP1, a combined oral-inhaled therapy to slow down the progression of early Alzheimer’s disease.
Who invested in AZTherapies
10 investors across 3 rounds
See all investors in AZTherapies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AZTherapies
Who invested in AZTherapies?
AZTherapies has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AZTherapies raised?
AZTherapies has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did AZTherapies last raise money?
AZTherapies's most recent round on record is a Series C, in Sep 2020.
What does AZTherapies do?
Founded in 2011 and based in Massachusetts, US, AZTherapies Inc.
Where is AZTherapies headquartered?
AZTherapies is headquartered in Boston, US.
Which VCs invest in companies like AZTherapies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at AZTherapies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like AZTherapies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.